CVS Health Assisting Customers Affected by Earthquakes in Puerto Rico

Top of the article

Company is providing impacted residents with advance prescription benefits, product donations

WOONSOCKET, R.I. CVS Health (NYSE: CVS) is committed to filling prescriptions, providing pharmacy services and providing other assistance in Puerto Rico following the trio of catastrophic earthquakes recorded this past week. The company is providing pharmacy services to members of La Administración de Seguros de Salud de Puerto Rico (ASES) to ensure the residents of Puerto Rico have expanded access to their medications during this time of need.

"As we continue to see the aftereffects of the earthquakes that continue to ravage Puerto Rico and surrounding islands, CVS Health is committed to providing critical care and services to its residents," said Brian Bosnic, Division Vice President, CVS Health. "CVS Pharmacy has been proactively reaching out to pharmacy patients via text message and email to alert them to our offerings during this time and as the situation unfolds."

CVS Pharmacy and CVS Caremark, CVS Health's pharmacy benefit management business, have activated a process that allows pharmacists in any of the 25 stores on the island to provide one-time emergency refills of a 10-day supply of medication for plan members. Patients taking specialty medications who are impacted in the areas affected by the earthquakes will be offered alternate delivery arrangements, including the use of courier services. On-site storage and refrigeration of specialty medications is also being offered to members without power to prevent spoilage.

In addition, CVS Health has partnered with the Hispanic Federation and donated $100,000 in product to residents and first responders, including personal care items such as diapers, baby wipes, sunscreen, toothbrushes and bug repellent, as well as clean-up products such as gloves, trash bags, face masks. Further, the CVS Pharmacy located in Ponce, the closest CVS location to most damaged area, will be distributing 42 pallets of free bottled water this Saturday, January 18, 2020, beginning at 10:00 AM ET. Residents can receive one case of water on a first-come-first-serve basis. Water will be distributed at the CVS Pharmacy located at 2511 Ponce Bypass, Ponce, Puerto Rico from 10:00 AM ET until 5:00 PM ET or while supplies last.

"We're deeply grateful to CVS for their generosity and the speed in which they moved to help us provide food, care and comfort to our people in Puerto Rico, said Frankie Miranda, President of Hispanic Federation. "Thanks to their commitment and caring, we have provided help and hope to those in greatest need.

To find a CVS Pharmacy near you, visit the store locator at http://www.cvs.com.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Press Contact

Stephanie Cunha
CVS Pharmacy
401-209-0755
Stephanie.Cunha@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

Keeping Community at the Center of Care at MinuteClinic

Bottom of the article

With approximately 1,100 locations nationwide, MinuteClinic nurse practitioners and physician assistants work every day to provide patients with convenient, personalized care that’s close to home.

One MinuteClinic provider who takes that work to heart is Aimee Kleppin, a family nurse practitioner who works out of a CVS Pharmacy in Queen Creek, Arizona.

Highly motivated and community-minded in her work, Kleppin was awarded a 2019 CVS Health Paragon Award, which recognizes the best-of-the-best among CVS Health colleagues who deliver direct care to patients and customers. Now in its 29th year, the Paragon Awards honor colleagues who embody the core values of CVS Health.

Born in Puerto Rico to parents who are both pharmacists, Kleppin knew from the time that she was in high school that she wanted to be a nurse practitioner. In her years of working for MinuteClinic, Kleppin has developed a following of patients who trust her clinical knowledge and appreciate her caring approach.

Watch above to learn about Kleppin’s dedication to her local community, including a program on hygiene that she developed the local schools, and why she’s continuously inspired to help others through her work.

Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
7
Display Hero
Off

CVS Health Applauds Introduction of Key Legislation Ensuring Kidney Transplant Patients Can Maintain Medicare Coverage of Immunosuppressive Drugs

Top of the article

WOONSOCKET, R.I. — CVS Health issued the following statement today regarding the introduction of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 in the United States Congress:

Tens of thousands of people in the United States have kidney transplants each year and taking immunosuppressant medications is key to the success of each patient’s journey. Unfortunately, when kidney patients are without health coverage, they too often stop taking these medications and in turn, redevelop kidney failure.  CVS Health applauds reintroduction of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, legislation that ensures kidney transplant patients can maintain access to Medicare Part B coverage for immunosuppressant drugs after it currently expires, if no other coverage is available.
 
As a company committed to patient-centric and clinically-optimal kidney care, we support policies like these that have the potential to improve the lives of kidney disease patients. CVS Health is focused on reshaping the patient experience through CVS Kidney Care and will continue to advance new kidney disease management programs while also developing new technologies to treat kidney failure. We applaud Representatives Michael Burgess (R-TX) and Ron Kind (D-WI) for championing this important legislation.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

CVS Health Corporation Announces Quarterly Dividend

Top of the article

WOONSOCKET, R.I. — CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation's common stock. The dividend is payable on February 3, 2020, to holders of record on January 23, 2020.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

CVS Health to Present at the 38th Annual J.P. Morgan Healthcare Conference

Top of the article

WOONSOCKET, R.I. CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, President and Chief Executive Officer, Eva Boratto, Executive Vice President and Chief Financial Officer, and Karen Lynch, Executive Vice President and President of Aetna will be speaking to investors at the J.P. Morgan Healthcare Conference on January 14, 2020, at approximately 10:00 a.m. PT.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

CVS Health Charity Classic Unveils $1 Million Donation to Local Non-Profits

Top of the article

2019 Charity Classic Support Brings Total Amount Donated to More Than $23 Million

WOONSOCKET, R.I. Today, CVS Health President and CEO, Larry Merlo and PGA TOUR Champions and CVS Health Charity Classic Co-hosts Brad Faxon and Billy Andrade came together to announce that the 2019 CVS Health Charity Classic generated $1 million for Southern New England charities. This brings the total amount donated over the last 21 years to more than $23 million.

"Over the past 21 years, the Charity Classic has had the pleasure of connecting with organizations that are making a significant impact in the communities that we live and work in," said Eileen Howard Boone, Tournament Chairperson of the CVS Health Charity Classic. "We are so honored to celebrate another charitable milestone with CVS Health colleagues, charity partners, Charity Classic sponsors and event volunteers."

The 2019 CVS Health Charity Classic featured some of the world's top professional golfers including Brooke Henderson, Colin Montgomerie and Keegan Bradley. The Event Series also attracted sold out crowds to Dunkin' Donuts Center for Crave RI. The two-day food festival displayed Rhode Island's diverse culinary scene with more than 250 local restaurants & beverage profiles in downtown Providence.

Looking ahead, CVS Health announced the date for the 2020 CVS Health Charity Classic. The Event Series will take place Thursday, June 18 through Monday, June 22.

The mission of the CVS Health Charity Classic is to give back to the community and provide assistance to charitable organizations that focus on helping the community year-round. Donations provided by the 2019 CVS Health Charity Classic provide vital funding to a range of programs serving children and families. In all, 86 non-profit organizations across Rhode Island and Southern Massachusetts will benefit this year from the CVS Health Charity Classic, including:

  • Sojourner House whose mission is to promote healthy relationships by providing culturally sensitive support, advocacy, and education for victims and survivors of domestic and sexual violence; and to effect systems change.
  • Tides Family Services that addresses the needs of at-risk children through services such as counseling and educational and court advocacy.
  • The Joe Andruzzi Foundation that is committed to providing help, hope, and a reason to smile, for New England cancer patients and their families by contributing financial support when it is needed most.

"The Joe Andruzzi Foundation is honored to be one of the longtime chosen charities of the CVS Health Charity Classic," said Joe Andruzzi, three-time New England Patriots Super Bowl Champion and Joe Andruzzi Foundation Co-Founder & Board Chair. "The generosity of CVS Health and the Charity Classic will help the Foundation to provide New England cancer patients and their families a chance to focus on recovery not bills."

Contacts

Michele Bates
Marketing & Communications Manager, Octagon
219-781-8833
Michele.Bates@octagon.com

About CVS Health Charity Classic

The CVS Health Charity Classic is one of Rhode Island's largest charitable event series, including a golf tournament featuring some of the world's top professional golfers and a two-day food festival highlighting local restaurants, breweries, and vineyards. Since its inception in 1999, the Charity Classic has donated more than $23 million for Southern New England nonprofit organizations that provide vital funding to a range of programs serving children and families. For additional information on the CVS Health Charity Classic, please visit www.cvshealthcharityclassic.com. Follow the Charity Classic on Facebook, Instagram, and Twitter for updates on the event as they happen.

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
2
Display Hero
Off

Taking Control of Diabetes with HealthHub

Bottom of the article

HealthHUB, our first-of-its-kind concept store now open in select locations nationwide, connects patients with health care services, advice and personalized care right at their neighborhood CVS Pharmacy. 

This ease of accessibility was what prompted Luis to stop by his local HealthHUB to see someone about abdominal pain he was experiencing.

What he and the nurse practitioner discovered was that the issues he was having went beyond simple pain: He was diabetic, but wasn’t currently being treated for the condition. Within his 40-minute visit, the HealthHUB team set Luis up to meet with both an eye doctor and a dietician and he left with a treatment and management plan in place.

Watch the video to learn more about how Luis’s trip to his local HealthHUB got him back on track.

To learn more about our enterprise-wide approach to diabetes management and care, visit our Managing Diabetes with CVS Health page.

To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our Leaders in Care newsletter.

Patient and doctor have a conversation
Hide Media Contacts (Sidebar)
No
Article
Hide Share
Off
"Likes" Count
8
Display Hero
Off

CVS Health Completes Rollout of Time Delay Safes in All of Its Virginia Pharmacies

Top of the article

New safes for controlled substances anticipated to help reduce robbery incidents

All 353 CVS Pharmacy locations in the state now using time-delay safe technology

WOONSOCKET, R.I. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), announced today that it has completed the rollout of time delay safes in all of its 353 CVS Pharmacy locations in Virginia, including pharmacies located in Target stores. The safes are anticipated to help prevent pharmacy robberies and the diversion of controlled substance narcotic medications by keeping them out of the hands of unauthorized individuals. In addition, the safes are anticipated to help CVS Pharmacy ensure the safety and well-being of its customers and employees.

CVS Pharmacy expects these time delay safes to help deter pharmacy robberies including those involving opioid medications such as oxycodone and hydrocodone by electronically delaying the time it takes for pharmacy employees to be able to open the safe. CVS Pharmacy first implemented time delay safes in Indianapolis, a city experiencing at the time a high volume of pharmacy robberies, in 2015. The company saw a 70 percent decline in pharmacy robberies among the Indianapolis stores where the time delay safes had been installed.

"Pharmacy robberies are a challenging issue for every pharmacy and we are committed to doing all we can to reduce the number of incidents in our Virginia stores," said Dick Dakessian, Division Leader for CVS Pharmacy. "We have seen that time delay safes, combined with other security policies and procedures in place at our stores, can greatly reduce these incidents and are pleased to roll out this enhanced security measure. These safes will help ensure that our pharmacies remain a safe environment for our patients and colleagues."

The time delay function cannot be overridden and is designed to serve as a deterrent to would-be pharmacy robbers whose goal is to enter and exit their robbery targets as quickly as possible. All CVS Pharmacy locations with time delay safes display visible signage warning that time delay safes are in use to prevent on-demand access to controlled substance narcotics.

CVS Health's time delay safe program is one of many company initiatives to help address and prevent prescription opioid misuse, diversion and abuse.

The company, for example, has expanded its Safe Medication Disposal Program in Virginia, completing the installation of 72 drug disposal kiosks in select CVS Pharmacy locations in communities across the state, adding to the 78 units previously donated to local law enforcement.

In 2020, the company will add 1,000 in-store safe medication disposal units to the more than 1,800 units currently in CVS Pharmacy locations nationwide. It will also donate up to 400 additional units to local police departments, in addition to the 1,000 units already donated to law enforcement. Together, the existing medication disposal units have collected more than 1.1 million pounds of unwanted or expired medications, including 66,600 pounds in Virginia.

Additionally, beginning next year, all CVS Pharmacy locations that do not offer a safe medication disposal kiosk will begin to offer DisposeRx packets at no cost to patients filling an opioid prescription for the first time. According to the manufacturer, when water and the DisposeRx powder are added to a pill bottle with unwanted prescription medications, the combination produces a biodegradable gel, allowing for safe disposal at home.

CVS Health's commitment to helping prevent and address prescription drug misuse also extends to community education and increasing access to the opioid overdose-reversal drug naloxone.

The company is collaborating with Discovery Education, tapping into their expertise in digital curriculum and content, to enhance CVS Health's prescription drug abuse prevention education program, Pharmacists Teach. The program, which has already reached more than 500,000 students and parents across the country, will aim to reach an additional 1.4 million people over three years following this investment.

Finally, CVS Pharmacy patients can now access the opioid overdose-reversal drug naloxone without an individual prescription at every CVS Pharmacy location nationwide, including all 50 states, Washington, D.C., and Puerto Rico. CVS Health has also worked with Google to help people locate naloxone at CVS Pharmacy and other locations in their local community using Google's locator tool.

To learn more about CVS Health's efforts to combat prescription drug misuse, visit our website.

About CVS Pharmacy

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Joe Goode
401-770-9820
Joseph.Goode@CVSHealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
1
Display Hero
Off

CVS Health Announces $750K in New Funding for California Harm Reduction Coalition

Top of the article

Three-year partnership will help support critical resources to address prescription opioid abuse across the state

OAKLAND, Calif. As part of its commitment to building healthier communities, CVS Health (NYSE: CVS) today announced it will be providing $750,000 over the next three years to the national Harm Reduction Coalition to improve the health and wellness of California residents impacted by prescription opioid misuse and abuse.

Harm Reduction Coalition, or HRC, is a national capacity-building and advocacy organization that promotes the health and dignity of individuals and communities affected by drug abuse and drug-related policies and provides a critical voice for those in the most vulnerable communities. The new funding from CVS Health will help support HRC as they tackle critical health issues faced by the California community related to prescription opioid misuse and abuse.

"We can help improve the health outcomes of our communities by strengthening our local support and empowering local organizations that are developing innovative solutions," said Kristen Miranda, California Market President for Aetna, a CVS Health company. "We know that so many communities across the country including in California have been impacted by widespread prescription opioid misuse and abuse. Our work with the HRC will support their efforts to address several elements of this significant public health issue in California and help local residents on their path to better health."

The funding will support HRC's Community Engagement Network to Expand Resources (CENTER) Initiative a three-year, state-wide effort designed to expand, develop and deepen harm reduction services throughout California. CENTER will be focused on convening diverse stakeholders to address drug-related stigmas, supporting syringe services programs with training and technical assistance, hosting state and national conferences and developing culturally relevant resources as a means to be better equipped to respond to the needs of people who misuse and abuse prescription drugs, their families, and impacted communities in California.

The CVS Health grant will be highlighted at a Harm Reduction Coalition training event and discussion taking place December 11 and 12 at the University of California, Fresno Center. The event is open to community members and service providers in the Central Valley that are focused on evidence-based strategies to address issues related to prescription opioid misuse and abuse.

"We have over 25 years of experience preventing overdose and drug-related harms through resources and education that are rooted in evidence and compassion," said Dr. Taeko Frost, Senior Director of Innovation and Strategy for Harm Reduction Coalition. "We know that harm reduction programs have been operating on shoestring budgets for years, only reaching the people most at risk of overdose. The CENTER Initiative will allow us to strengthen those programs through training and capacity-building, to build partnerships with other local programs, including health care providers and drug treatment access points, and to create a comprehensive statewide network for providers who can meaningfully engage with at-risk community members."

Building Healthier Communities by Addressing Prescription Opioid Misuse and Abuse

The grant is part of CVS Health's Building Healthier Communities initiative, which is a commitment to making community health and wellness central to the newly combined company's charge for a better world. Through Building Healthier Communities, CVS Health and its charitable foundations will support a range of initiatives and non-profit organizations across three categories: improving local access to affordable quality care; impacting public health challenges; and partnering with local communities.

One of the primary public health issues the company is addressing is the impact of the misuse and abuse of prescription opioids in communities around the country. CVS Health and Aetna's expansive reach, expertise and access to local communities position us to help fight prescription opioid abuse for the people we serve. Our comprehensive strategy focused on prevention, intervention and support, builds on years of innovative programs and allows us to identify new opportunities for impact. The company has made an enterprise-wide commitment to help address the inappropriate use of prescription opioids by designing programs that increase access to safe medication disposal, encourage appropriate utilization, educate patients at the pharmacy and teens and parents in communities, expand access to life-saving antidotes, work with providers to ensure they are following evidence-based opioid prescribing guidelines, and support local recovery programs.

This grant is part of CVS Health's commitment to investing in California's health care delivery system, reflected in the November 2018 agreement between CVS Health and California's Department of Managed Health Care (DMHC).

About Harm Reduction Coalition

Harm Reduction Coalition is a national advocacy and capacity-building organization that promotes the health and dignity of individuals and communities impacted by drug use. Our efforts advance harm reduction policies, practices and programs that address the adverse effects of drug use including overdose, HIV, hepatitis C, addiction, and incarceration. Recognizing that social inequality and injustice magnify drug-related harm and limit the voice of our most vulnerable communities, we work to uphold every individual's right to health and well-being and their competence to participate in the public policy dialogue.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Ethan Slavin
860-273-6095
SlavinE@aetna.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
0
Display Hero
Off

CVS Health Launches Transform Oncology Care Program to Help Improve Patient Outcomes and Lower Overall Costs

Top of the article

New precision medicine strategy uses the latest genomics science and technology to help providers identify and start their patients on the best cancer treatment, faster

Comprehensive oncology management program includes enterprise capabilities to help address significant challenges at every point of the cancer care journey

WOONSOCKET, R.I. CVS Health (NYSE: CVS) today announced Transform Oncology Care , anchored on a first-of-its-kind precision medicine strategy for payors. The program uses genomic testing results at the point-of-prescribing to help patients start on the best treatment, faster and in addition, matches eligible patients to clinical trials. Transform Oncology Care also uses the Company's local footprint and unique assets to improve patient outcomes and lower overall costs at every point of the cancer care journey.

"Timing in cancer care is everything and when a patient does not get started on the right treatment it can result in progression and higher costs," said Alan Lotvin, M.D., Executive Vice President and Chief Transformation Officer, CVS Health. "We are the first company working to make the latest in precision medicine accessible to more patients and further empower informed treatment decision-making based on a patient's genetic profile to give them the best chance for successful treatment and improved quality-of-life."

Connecting Guidelines to Genetic Testing for the Best Treatment, Faster

The innovative precision medicine strategy, delivered in close coordination with oncologists, uses results of broad-panel gene sequencing tests and the latest National Comprehensive Cancer Network (NCCN) treatment and supportive care guidelines to help oncologists identify and start their patients on the most precise, appropriate treatment regimen based on their clinical and genetic profiles. Therapeutic regimens that align to NCCN guidelines, including those matched with the results of the broad-panel gene sequencing tests, will automatically receive prior authorization approval, speeding time to start of the therapy for patients. The strategy is enabled by an innovative collaboration with Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

"CVS Health is making great strides in advancing patient care, and we are thrilled to contribute the benefits of genomic testing to these efforts," said Ryan Fukushima, Chief Operating Officer of Tempus. "We believe this collaboration has real potential to personalize treatment for patients while also reducing the total cost of care."

Today, the majority of cancers when diagnosed early can be effectively managed, treated or even cured.https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf For patients diagnosed with late-stage cancers, however, many can benefit from advanced genomic testing, yet very few eligible patients receive this type of testing today. This can inhibit the start of the most appropriate treatment and result in cancer progression and higher costs. For these patients, a web-based provider portal, built into the e-prescribing workflow, informs oncologists of the availability of Tempus' broad-panel gene sequencing tests at diagnosis, which are more comprehensive than the single-gene tests that are used today. The broad-panel tests identify a patient's genomic variants and the therapeutic options specific to their molecular and clinical profile. The testing results also match and help support the rapid enrollment of eligible patients in local clinical trials through Tempus' proprietary platform, facilitating broader access to experimental therapies. In addition, the portal provides oncologists real-time access to the latest NCCN guidelines at the point-of-prescribing.

The program includes CVS Health nurse-led care management, integrated with payor's existing programs, to create a more personalized experience for patients and their caregivers and close existing gaps in care. In addition, payors can adopt value-based contracts that employ provider networks to drive high-quality care and lower costs. Transform Oncology Care also uses the CVS Health's accessible, local footprint, connected data and integrated systems to help better identify and intervene with patients who could benefit from preventive or screening services.

Transform Oncology Care is available to other health plans. Aetna has adopted the program for fully insured commercial populations and is rolling it out with participating Aetna provider networks in 12 states.

About CVS Health

CVS Health is the nation's premier health innovation company helping people on their path to better health. Whether in one of its pharmacies or through its health services and plans, CVS Health is pioneering a bold new approach to total health by making quality care more affordable, accessible, simple and seamless. CVS Health is community-based and locally focused, engaging consumers with the care they need when and where they need it. The Company has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 102 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 38 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact

Christina Beckerman
401-770-8868
Christina.Beckerman@cvshealth.com

Investor Contact

Valerie Haertel
401-770-4050
Valerie.Haertel@cvshealth.com

Hide Media Contacts (Sidebar)
No
Press Release
Hide Share
Off
"Likes" Count
9
Display Hero
Off